IOB.ch

At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), we unite researchers and clinicians to restore vision.

[IOB.ch @IOB_ch]

👏 Warm congratulations from IOB to Katherine A. High, Jean Bennett & Albert Maguire on the 2026 Breakthrough Prize in Life Sciences!

Katherine High, CEO of our first spin-off, RhyGaze, brings scientific rigor together with a clear focus on delivering therapies for vision loss to patients.

We are pleased to celebrate this well-deserved recognition!
🔗 More details: https://t.co/4ANif0e73q

[IOB.ch @IOB_ch]

👁‍🗨We turn science into sight.
Congratulations to our Director @IOB_Roska on receiving the 2026 Future Vision Award alongside Connie Cepko & Daniel Ting. A recognition of long-term research now reaching patients.
🎬Watch the short movies: https://t.co/mbWgbGdpbN
#Vision #Retina #Ophthalmology #Blindness #Neuroscience #ScienceInnovation #VisionRestoration #EyeHealth #BiomedicalResearch

[nature @Nature]

The work could help to explain why the risk of developing some brain conditions — such as schizophrenia and Alzheimer’s disease — differs between males and females
https://t.co/yTapGz5kE4

[Temurkhan Ayupov @AyupovTemurkhan]

Very nice News & Views article on our work by Samantha Krysa and Jonathan Brestoff.
@Nature @NaturePortfolio @IOB_ch

#MitoCatch #Mitochondria #Neurodegeneration
https://t.co/BvyqHbNyhK

[Nature Biotechnology @NatureBiotech]

The mitochondrion-targeting tool MitoCatch brings mitochondria into specific cell types through cell-surface-targeted binders. #NBThighlight https://t.co/3y0P6oILBI

[IOB.ch @IOB_ch]

🚀A potential paradigm shift for diseases linked to mitochondrial dysfunction.
📄 Published in @Nature: https://t.co/MyCeZJ7UVO

#MitoCatch #NatureJournal #Mitochondria #PrecisionMedicine #CellTherapy #Neuroscience #VisionResearch #BiotechInnovation #LHON #OpticNeuropathies

[IOB.ch @IOB_ch]

💡What if we could reboot sick cells?

IOB scientists @AyupovTemurkhan, @v_moreno_juan and collaborators led by @IOB_Roska have developed #MitoCatch, a system that delivers healthy mitochondria directly to diseased cells. A step toward precision mitochondrial medicine.
🧵👇

[IOB.ch @IOB_ch]

✨Key findings: MitoCatch delivers mitochondria to key cell types with higher efficiency. Transferred mitochondria remain functional and targeted cells’ survival is improved.

[IOB.ch @IOB_ch]

🔬 #MitoCatch uses engineered protein binders, like a cellular GPS, to guide mitochondria exactly where they are needed. Three complementary versions of #MitoCatch enable targeted delivery.

[IOB.ch @IOB_ch]

⚡ Mitochondria power our cells.
When they fail, diseases like optic nerve degeneration, Parkinson’s, or heart failure can follow. Getting healthy mitochondria to the right cells has been a major challenge.

[IOB.ch @IOB_ch]

🌍 This gives researchers worldwide a powerful starting point to develop therapies to preserve vision.
#Ophthalmology #OpenScience #VisionResearch #DrugDiscovery #Organoids #Retina

[IOB.ch @IOB_ch]

👁️ What keeps vision cells alive?
A new study just published in Neuron (@StefanESpirig, @AlvaroHerrero1 et al.) screened 2,700+ compounds across 20,000 lab grown human retinas to find out.

🧵👇

[IOB.ch @IOB_ch]

✨The full dataset is openly available, including compounds, targets, and effects.
🔗https://t.co/dwX6tOsAsN

[IOB.ch @IOB_ch]

Potential impact across journalism, law, and science.
📄 Published in Nature Electronics: https://t.co/4tN9IKfB7u

#Deepfakes #AI #Cybersecurity #DigitalTrust #ETHZurich #Science

[IOB.ch @IOB_ch]

🤖As deepfakes rise, a chip could bring back trust
A new sensor technology secures images, videos, and data at capture, making manipulation detectable.
🧵👇

[IOB.ch @IOB_ch]

🧪Developed by: @FelixFranke7 (IOB), Fernando Cardes García from Andreas Hierlemann’s lab @ETH_en, financially supported by the Swiss National Science Foundation (SNSF) and the State Secretariat for Education, Research and Innovation (SERI) through the SwissChips initiative.